Dehydration ||| S:0 E:11 ||| NNP
,  ||| S:11 E:13 ||| ,
electrolyte  ||| S:13 E:25 ||| JJ
imbalances  ||| S:25 E:36 ||| NNS
and  ||| S:36 E:40 ||| CC
renin-angiotensin-aldosterone-vasopressin  ||| S:40 E:82 ||| JJ
axis  ||| S:82 E:87 ||| NN
in  ||| S:87 E:90 ||| IN
successful  ||| S:90 E:101 ||| JJ
and  ||| S:101 E:105 ||| CC
unsuccessful  ||| S:105 E:118 ||| JJ
endurance  ||| S:118 E:128 ||| JJ
horses  ||| S:128 E:135 ||| NNS
Limited  ||| S:135 E:143 ||| JJ
information  ||| S:143 E:155 ||| NN
exists  ||| S:155 E:162 ||| VBZ
concerning  ||| S:162 E:173 ||| VBG
the  ||| S:173 E:177 ||| DT
defence  ||| S:177 E:185 ||| NN
of  ||| S:185 E:188 ||| IN
homeostasis  ||| S:188 E:200 ||| NN
during  ||| S:200 E:207 ||| IN
endurance  ||| S:207 E:217 ||| JJ
competitions  ||| S:217 E:230 ||| NNS
and  ||| S:230 E:234 ||| CC
the  ||| S:234 E:238 ||| DT
relationship  ||| S:238 E:251 ||| NN
with  ||| S:251 E:256 ||| IN
performance ||| S:256 E:267 ||| NN
.  ||| S:267 E:269 ||| .
This  ||| S:269 E:274 ||| DT
research  ||| S:274 E:283 ||| NN
analysed  ||| S:283 E:292 ||| NN
renin  ||| S:292 E:298 ||| NNS
( ||| S:298 E:299 ||| -LRB-
REN ||| S:299 E:302 ||| NNP
) ||| S:302 E:303 ||| -RRB-
,  ||| S:303 E:305 ||| ,
angiotensin  ||| S:305 E:317 ||| VBG
II  ||| S:317 E:320 ||| NNP
( ||| S:320 E:321 ||| -LRB-
ANG ||| S:321 E:324 ||| NNP
) ||| S:324 E:325 ||| -RRB-
,  ||| S:325 E:327 ||| ,
aldosterone  ||| S:327 E:339 ||| NNS
( ||| S:339 E:340 ||| -LRB-
ALD ||| S:340 E:343 ||| NNP
)  ||| S:343 E:345 ||| -RRB-
and  ||| S:345 E:349 ||| CC
vasopressin  ||| S:349 E:361 ||| NNS
( ||| S:361 E:362 ||| -LRB-
AVP ||| S:362 E:365 ||| NNP
)  ||| S:365 E:367 ||| -RRB-
in  ||| S:367 E:370 ||| IN
horses  ||| S:370 E:377 ||| NNS
covering  ||| S:377 E:386 ||| VBG
different  ||| S:386 E:396 ||| JJ
distances ||| S:396 E:405 ||| NNS
,  ||| S:405 E:407 ||| ,
assesses  ||| S:407 E:416 ||| JJ
differences  ||| S:416 E:428 ||| NNS
between  ||| S:428 E:436 ||| IN
successful  ||| S:436 E:447 ||| JJ
and  ||| S:447 E:451 ||| CC
eliminated  ||| S:451 E:462 ||| VBN
horses  ||| S:462 E:469 ||| NNS
and  ||| S:469 E:473 ||| CC
evaluates  ||| S:473 E:483 ||| VBZ
correlations  ||| S:483 E:496 ||| VBN
between  ||| S:496 E:504 ||| IN
hydration  ||| S:504 E:514 ||| JJ
status ||| S:514 E:520 ||| NN
,  ||| S:520 E:522 ||| ,
renal  ||| S:522 E:528 ||| JJ
function ||| S:528 E:536 ||| NN
,  ||| S:536 E:538 ||| ,
electrolytes ||| S:538 E:550 ||| NN
,  ||| S:550 E:552 ||| ,
REN ||| S:552 E:555 ||| NNP
,  ||| S:555 E:557 ||| ,
ANG ||| S:557 E:560 ||| NNP
,  ||| S:560 E:562 ||| ,
ALD  ||| S:562 E:566 ||| NNP
and  ||| S:566 E:570 ||| CC
AVP ||| S:570 E:573 ||| NNP
.  ||| S:573 E:575 ||| .
Packed  ||| S:575 E:582 ||| JJ
cell  ||| S:582 E:587 ||| NN
volume  ||| S:587 E:594 ||| NN
( ||| S:594 E:595 ||| -LRB-
PCV ||| S:595 E:598 ||| NNP
) ||| S:598 E:599 ||| -RRB-
,  ||| S:599 E:601 ||| ,
velocity  ||| S:601 E:610 ||| NN
and  ||| S:610 E:614 ||| CC
serum  ||| S:614 E:620 ||| JJ
concentrations  ||| S:620 E:635 ||| NNS
of  ||| S:635 E:638 ||| IN
REN ||| S:638 E:641 ||| NNP
,  ||| S:641 E:643 ||| ,
ANG ||| S:643 E:646 ||| NNP
,  ||| S:646 E:648 ||| ,
ALD ||| S:648 E:651 ||| NNP
,  ||| S:651 E:653 ||| ,
AVP ||| S:653 E:656 ||| NNP
,  ||| S:656 E:658 ||| ,
Na ||| S:658 E:660 ||| NNP
,  ||| S:660 E:662 ||| ,
K ||| S:662 E:663 ||| NNP
,  ||| S:663 E:665 ||| ,
Cl ||| S:665 E:667 ||| NNP
,  ||| S:667 E:669 ||| ,
Ca ||| S:669 E:671 ||| NNP
,  ||| S:671 E:673 ||| ,
Mg ||| S:673 E:675 ||| NNP
,  ||| S:675 E:677 ||| ,
P ||| S:677 E:678 ||| NN
,  ||| S:678 E:680 ||| ,
creatine  ||| S:680 E:689 ||| JJ
kinase ||| S:689 E:695 ||| NN
,  ||| S:695 E:697 ||| ,
aspartate  ||| S:697 E:707 ||| JJ
aminotransferase ||| S:707 E:723 ||| NN
,  ||| S:723 E:725 ||| ,
lactate  ||| S:725 E:733 ||| JJ
dehydrogenase ||| S:733 E:746 ||| NN
,  ||| S:746 E:748 ||| ,
total  ||| S:748 E:754 ||| JJ
proteins  ||| S:754 E:763 ||| NNS
( ||| S:763 E:764 ||| -LRB-
TSP ||| S:764 E:767 ||| NNP
) ||| S:767 E:768 ||| -RRB-
,  ||| S:768 E:770 ||| ,
albumin  ||| S:770 E:778 ||| NNS
( ||| S:778 E:779 ||| -LRB-
ALB ||| S:779 E:782 ||| NNP
) ||| S:782 E:783 ||| -RRB-
,  ||| S:783 E:785 ||| ,
serum  ||| S:785 E:791 ||| FW
uric  ||| S:791 E:796 ||| FW
nitrogen  ||| S:796 E:805 ||| FW
( ||| S:805 E:806 ||| -LRB-
SUN ||| S:806 E:809 ||| NNP
) ||| S:809 E:810 ||| -RRB-
,  ||| S:810 E:812 ||| ,
creatinine  ||| S:812 E:823 ||| NNS
( ||| S:823 E:824 ||| -LRB-
CREAT ||| S:824 E:829 ||| NNP
)  ||| S:829 E:831 ||| -RRB-
and  ||| S:831 E:835 ||| CC
lactate  ||| S:835 E:843 ||| NNS
were  ||| S:843 E:848 ||| VBD
analysed  ||| S:848 E:857 ||| VBN
in  ||| S:857 E:860 ||| IN
both  ||| S:860 E:865 ||| DT
successful  ||| S:865 E:876 ||| JJ
horses  ||| S:876 E:883 ||| NNS
( ||| S:883 E:884 ||| -LRB-
SH ||| S:884 E:886 ||| NNP
)  ||| S:886 E:888 ||| -RRB-
and  ||| S:888 E:892 ||| CC
in  ||| S:892 E:895 ||| IN
horses  ||| S:895 E:902 ||| NNS
eliminated  ||| S:902 E:913 ||| VBD
due  ||| S:913 E:917 ||| JJ
to  ||| S:917 E:920 ||| TO
metabolic  ||| S:920 E:930 ||| VB
problems  ||| S:930 E:939 ||| NNS
( ||| S:939 E:940 ||| -LRB-
MH ||| S:940 E:942 ||| NNP
) ||| S:942 E:943 ||| -RRB-
.  ||| S:943 E:945 ||| .
Two  ||| S:945 E:949 ||| CD
types  ||| S:949 E:955 ||| NNS
of  ||| S:955 E:958 ||| IN
competition  ||| S:958 E:970 ||| NN
were  ||| S:970 E:975 ||| VBD
studied ||| S:975 E:982 ||| VBN
:  ||| S:982 E:984 ||| :
91  ||| S:984 E:987 ||| CD
km  ||| S:987 E:990 ||| NN
in  ||| S:990 E:993 ||| IN
one  ||| S:993 E:997 ||| CD
day  ||| S:997 E:1001 ||| NN
( ||| S:1001 E:1002 ||| -LRB-
Competition  ||| S:1002 E:1014 ||| NNP
A ||| S:1014 E:1015 ||| NNP
:  ||| S:1015 E:1017 ||| :
20  ||| S:1017 E:1020 ||| CD
SH ||| S:1020 E:1022 ||| NNP
,  ||| S:1022 E:1024 ||| ,
9  ||| S:1024 E:1026 ||| CD
MH ||| S:1026 E:1028 ||| NNP
)  ||| S:1028 E:1030 ||| -RRB-
and  ||| S:1030 E:1034 ||| CC
166  ||| S:1034 E:1038 ||| CD
km  ||| S:1038 E:1041 ||| NN
in  ||| S:1041 E:1044 ||| IN
2  ||| S:1044 E:1046 ||| CD
days ||| S:1046 E:1050 ||| NNS
,  ||| S:1050 E:1052 ||| ,
83  ||| S:1052 E:1055 ||| CD
km ||| S:1055 E:1057 ||| CD
/ ||| S:1057 E:1058 ||| CD
day  ||| S:1058 E:1062 ||| NN
( ||| S:1062 E:1063 ||| -LRB-
Competition  ||| S:1063 E:1075 ||| NNP
B ||| S:1075 E:1076 ||| NNP
:  ||| S:1076 E:1078 ||| :
10  ||| S:1078 E:1081 ||| CD
SH  ||| S:1081 E:1084 ||| NNP
and  ||| S:1084 E:1088 ||| CC
5  ||| S:1088 E:1090 ||| CD
MH ||| S:1090 E:1092 ||| NNP
) ||| S:1092 E:1093 ||| -RRB-
.  ||| S:1093 E:1095 ||| .
Research  ||| S:1095 E:1104 ||| NNP
analysed  ||| S:1104 E:1113 ||| NN
renin  ||| S:1113 E:1119 ||| NNS
was  ||| S:1119 E:1123 ||| VBD
not  ||| S:1123 E:1127 ||| RB
affected  ||| S:1127 E:1136 ||| VBN
by  ||| S:1136 E:1139 ||| IN
exercise ||| S:1139 E:1147 ||| NN
,  ||| S:1147 E:1149 ||| ,
whereas  ||| S:1149 E:1157 ||| IN
ANG ||| S:1157 E:1160 ||| NNP
,  ||| S:1160 E:1162 ||| ,
ALD  ||| S:1162 E:1166 ||| NNP
and  ||| S:1166 E:1170 ||| CC
AVP  ||| S:1170 E:1174 ||| NNP
increased ||| S:1174 E:1183 ||| VBD
.  ||| S:1183 E:1185 ||| .
In  ||| S:1185 E:1188 ||| IN
the  ||| S:1188 E:1192 ||| DT
SH  ||| S:1192 E:1195 ||| NNP
group ||| S:1195 E:1200 ||| NN
,  ||| S:1200 E:1202 ||| ,
resting  ||| S:1202 E:1210 ||| VBG
ALD  ||| S:1210 E:1214 ||| NNP
and  ||| S:1214 E:1218 ||| CC
AVP  ||| S:1218 E:1222 ||| NNP
concentrations  ||| S:1222 E:1237 ||| NNS
at  ||| S:1237 E:1240 ||| IN
the  ||| S:1240 E:1244 ||| DT
beginning  ||| S:1244 E:1254 ||| NN
of  ||| S:1254 E:1257 ||| IN
the  ||| S:1257 E:1261 ||| DT
second  ||| S:1261 E:1268 ||| JJ
day  ||| S:1268 E:1272 ||| NN
of  ||| S:1272 E:1275 ||| IN
Competition  ||| S:1275 E:1287 ||| NNP
B  ||| S:1287 E:1289 ||| NNP
were  ||| S:1289 E:1294 ||| VBD
higher  ||| S:1294 E:1301 ||| JJR
than  ||| S:1301 E:1306 ||| IN
preride  ||| S:1306 E:1314 ||| JJ
values ||| S:1314 E:1320 ||| NNS
.  ||| S:1320 E:1322 ||| .
Vasopressin  ||| S:1322 E:1334 ||| NNP
did  ||| S:1334 E:1338 ||| VBD
not  ||| S:1338 E:1342 ||| RB
change  ||| S:1342 E:1349 ||| VB
during  ||| S:1349 E:1356 ||| IN
the  ||| S:1356 E:1360 ||| DT
second  ||| S:1360 E:1367 ||| JJ
day  ||| S:1367 E:1371 ||| NN
of  ||| S:1371 E:1374 ||| IN
Competition  ||| S:1374 E:1386 ||| NNP
B ||| S:1386 E:1387 ||| NNP
,  ||| S:1387 E:1389 ||| ,
whereas  ||| S:1389 E:1397 ||| IN
ALD  ||| S:1397 E:1401 ||| NNP
progressively  ||| S:1401 E:1415 ||| RB
increased ||| S:1415 E:1424 ||| VBN
.  ||| S:1424 E:1426 ||| .
Metabolic  ||| S:1426 E:1436 ||| JJ
problems  ||| S:1436 E:1445 ||| NNS
of  ||| S:1445 E:1448 ||| IN
both  ||| S:1448 E:1453 ||| DT
groups  ||| S:1453 E:1460 ||| NNS
showed  ||| S:1460 E:1467 ||| VBD
more  ||| S:1467 E:1472 ||| RBR
evident  ||| S:1472 E:1480 ||| JJ
dehydration  ||| S:1480 E:1492 ||| NNS
( ||| S:1492 E:1493 ||| -LRB-
higher  ||| S:1493 E:1500 ||| JJR
PCV ||| S:1500 E:1503 ||| NNP
,  ||| S:1503 E:1505 ||| ,
TSP ||| S:1505 E:1508 ||| NNP
,  ||| S:1508 E:1510 ||| ,
ALB ||| S:1510 E:1513 ||| NNP
,  ||| S:1513 E:1515 ||| ,
SUN  ||| S:1515 E:1519 ||| NNP
and  ||| S:1519 E:1523 ||| CC
CREAT ||| S:1523 E:1528 ||| NNP
)  ||| S:1528 E:1530 ||| -RRB-
and  ||| S:1530 E:1534 ||| CC
electrolyte  ||| S:1534 E:1546 ||| JJ
alterations  ||| S:1546 E:1558 ||| NNS
( ||| S:1558 E:1559 ||| -LRB-
more  ||| S:1559 E:1564 ||| JJR
intense  ||| S:1564 E:1572 ||| JJ
decreases  ||| S:1572 E:1582 ||| NNS
of  ||| S:1582 E:1585 ||| IN
Na  ||| S:1585 E:1588 ||| NNP
and  ||| S:1588 E:1592 ||| CC
Cl ||| S:1592 E:1594 ||| NNP
)  ||| S:1594 E:1596 ||| -RRB-
than  ||| S:1596 E:1601 ||| IN
SH  ||| S:1601 E:1604 ||| NNP
at  ||| S:1604 E:1607 ||| IN
the  ||| S:1607 E:1611 ||| DT
different  ||| S:1611 E:1621 ||| JJ
sampling  ||| S:1621 E:1630 ||| JJ
times ||| S:1630 E:1635 ||| NNS
.  ||| S:1635 E:1637 ||| .
Metabolic  ||| S:1637 E:1647 ||| JJ
problems  ||| S:1647 E:1656 ||| NNS
presented  ||| S:1656 E:1666 ||| VBD
higher  ||| S:1666 E:1673 ||| JJR
ALD  ||| S:1673 E:1677 ||| NNP
and  ||| S:1677 E:1681 ||| CC
AVP  ||| S:1681 E:1685 ||| NNP
concentrations ||| S:1685 E:1699 ||| NNS
.  ||| S:1699 E:1701 ||| .
Angiotensin  ||| S:1701 E:1713 ||| NNP
II  ||| S:1713 E:1716 ||| NNP
was  ||| S:1716 E:1720 ||| VBD
higher  ||| S:1720 E:1727 ||| JJR
at  ||| S:1727 E:1730 ||| IN
certain  ||| S:1730 E:1738 ||| JJ
sampling  ||| S:1738 E:1747 ||| JJ
times  ||| S:1747 E:1753 ||| NNS
in  ||| S:1753 E:1756 ||| IN
the  ||| S:1756 E:1760 ||| DT
horses ||| S:1760 E:1766 ||| NNS
.  ||| S:1766 E:1768 ||| .
Endurance  ||| S:1768 E:1778 ||| JJ
horses  ||| S:1778 E:1785 ||| NNS
with  ||| S:1785 E:1790 ||| IN
dehydration  ||| S:1790 E:1802 ||| NN
and  ||| S:1802 E:1806 ||| CC
electrolyte  ||| S:1806 E:1818 ||| JJ
disturbances  ||| S:1818 E:1831 ||| NNS
showed  ||| S:1831 E:1838 ||| VBD
a  ||| S:1838 E:1840 ||| DT
more  ||| S:1840 E:1845 ||| RBR
intense  ||| S:1845 E:1853 ||| JJ
activation  ||| S:1853 E:1864 ||| NN
of  ||| S:1864 E:1867 ||| IN
the  ||| S:1867 E:1871 ||| DT
REN-ANG-ALD-AVP  ||| S:1871 E:1887 ||| JJ
axis ||| S:1887 E:1891 ||| NN
.  ||| S:1891 E:1893 ||| .
The  ||| S:1893 E:1897 ||| DT
study  ||| S:1897 E:1903 ||| NN
of  ||| S:1903 E:1906 ||| IN
the  ||| S:1906 E:1910 ||| DT
response  ||| S:1910 E:1919 ||| NN
of  ||| S:1919 E:1922 ||| IN
the  ||| S:1922 E:1926 ||| DT
REN-ANG-ALD-AVP  ||| S:1926 E:1942 ||| JJ
axis  ||| S:1942 E:1947 ||| NN
during  ||| S:1947 E:1954 ||| IN
prolonged  ||| S:1954 E:1964 ||| JJ
exercise  ||| S:1964 E:1973 ||| NN
in  ||| S:1973 E:1976 ||| IN
horses  ||| S:1976 E:1983 ||| NNS
with  ||| S:1983 E:1988 ||| IN
different  ||| S:1988 E:1998 ||| JJ
performance  ||| S:1998 E:2010 ||| NN
will  ||| S:2010 E:2015 ||| MD
aid  ||| S:2015 E:2019 ||| VB
to  ||| S:2019 E:2022 ||| TO
minimise  ||| S:2022 E:2031 ||| VB
the  ||| S:2031 E:2035 ||| DT
risk  ||| S:2035 E:2040 ||| NN
of  ||| S:2040 E:2043 ||| IN
metabolic  ||| S:2043 E:2053 ||| JJ
diseases  ||| S:2053 E:2062 ||| NNS
during  ||| S:2062 E:2069 ||| IN
competitions ||| S:2069 E:2081 ||| NNS
.  ||| S:2081 E:2083 ||| .
